#carotid artery stenosis treatment cost | Explore Tumblr posts and blogs

drsumitblog · 5 days ago

Text

Carotid Artery Stenosis Treatment Cost in India: Complete Guide

Carotid Artery Stenosis (CAS) is a critical condition where the carotid arteries, which supply blood to the brain, become narrowed due to plaque buildup. This narrowing can increase the risk of stroke, making early detection and treatment vital. If you or a loved one is diagnosed with Carotid Artery Stenosis, you may have several questions, especially regarding the carotid artery stenosis treatment cost in India. Understanding the treatment options, associated costs, and the advantages of seeking treatment in India can help you make informed decisions.

India has become a preferred destination for carotid artery blockage treatment, offering advanced medical care at competitive prices. With renowned specialists such as Dr. Sumit Kapadia leading the field, India is known for providing high-quality healthcare at a fraction of the cost compared to Western countries.

In this comprehensive guide, we will delve into the treatment options available for Carotid Artery Disease, the carotid artery stenosis symptoms, and the cost of treatment. We’ll also explore the reasons why India is considered a top choice for treatment and the role of a vein specialist doctor near me in managing the condition effectively.

Overview of Treatment Options

The treatment for carotid artery stenosis typically depends on the severity of the condition and the presence of symptoms. In most cases, treatment aims to prevent a stroke by improving blood flow through the carotid arteries. The key treatments include:

Lifestyle Changes and Medication For those with mild carotid artery stenosis or early-stage carotid artery blockage, the doctor may recommend lifestyle changes, such as adopting a heart-healthy diet, exercising regularly, and quitting smoking. Medications may also be prescribed to reduce cholesterol, prevent blood clots, and control blood pressure.

Carotid Angioplasty and Stenting In more advanced cases, where there is significant narrowing of the artery, a procedure known as carotid angioplasty may be necessary. This minimally invasive procedure involves inserting a stent into the blocked carotid artery to help keep it open and restore normal blood flow. This treatment is especially beneficial for patients who cannot undergo surgery due to medical reasons.

Carotid Endarterectomy For severe carotid artery blockage, carotid endarterectomy is the gold standard treatment. It involves surgically removing the plaque from the artery, allowing blood to flow freely again. This procedure is typically recommended when the blockage is greater than 70% and is associated with a high risk of stroke.

Carotid Artery Bypass Surgery In rare cases, a carotid artery bypass surgery may be necessary. This procedure is used to reroute blood flow around a severely blocked or narrowed carotid artery. It’s typically considered when other treatments are not effective or feasible.

Carotid Doppler Test Before any treatment, a carotid Doppler test is often performed to assess the degree of carotid artery stenosis. This non-invasive test uses sound waves to create an image of the blood flow in the carotid arteries, helping doctors determine the severity of the blockage and decide on the appropriate treatment.

Cost of Carotid Artery Stenosis Treatment in India

One of the primary reasons why many individuals opt for carotid artery stenosis treatment in India is the cost-effectiveness of healthcare services. India offers world-class medical care at a fraction of the cost compared to countries like the US, the UK, and others. The carotid artery stenosis treatment cost in India is generally lower due to factors such as lower labour costs, affordable medical infrastructure, and competitive pricing strategies by hospitals.

While the cost of carotid artery blockage treatment varies depending on the type of treatment required, here is an estimated breakdown of the costs associated with different procedures:

Consultation with a Vein Specialist Doctor Consultation with an expert like a vein specialist doctor near me typically costs around ₹1,000 to ₹3,000 in India. The cost may vary based on the location of the clinic and the doctor's experience.

Carotid Doppler Test The carotid Doppler test cost in India is typically between ₹2,000 and ₹5,000. This test is crucial for diagnosing carotid artery stenosis and determining the appropriate course of action for treatment.

Carotid Angioplasty and Stenting The cost of carotid angioplasty and stenting in India is relatively affordable compared to Western countries. The price range for this procedure is approximately ₹1,00,000 to ₹2,50,000. This cost includes the procedure, stent insertion, and hospital stay.

Carotid Endarterectomy Carotid endarterectomy, the most common surgery for carotid artery blockage, typically costs between ₹1,50,000 to ₹3,50,000 in India. The cost may increase if the surgery involves complications or a longer hospital stay.

Carotid Artery Bypass Surgery In cases where carotid artery bypass surgery is needed, the cost may range from ₹2,00,000 to ₹5,00,000. This surgery is more complex and involves a longer recovery time, so the cost reflects the more extensive nature of the procedure.

Follow-up Care and Medication After the treatment, follow-up visits and medication are necessary to ensure the success of the procedure and prevent complications. These costs can vary, but on average, patients may need to budget around ₹10,000 to ₹20,000 per year for medication and follow-up care.

While these costs may seem high, they are significantly lower than what you would pay for similar procedures in the US or the UK, where the cost can be upwards of ₹10,00,000 for carotid artery stenosis treatment.

Why Choose India for Carotid Artery Stenosis Treatment?

India has gained recognition as a top destination for medical tourism due to its world-class healthcare facilities, experienced doctors, and cost-effective treatment options. Here are some reasons why you should consider India for carotid artery stenosis treatment:

High-Quality Healthcare India boasts state-of-the-art medical facilities equipped with the latest technology for the diagnosis and treatment of Carotid Artery Disease. Hospitals like Apollo, Fortis, and Kokilaben Dhirubhai Ambani Hospital are internationally recognised for their excellence in cardiology and vascular treatments. These hospitals are accredited by international bodies like the Joint Commission International (JCI) and National Accreditation Board for Hospitals (NABH), ensuring the highest quality of care.

Experienced Specialists India is home to some of the world’s most renowned carotid artery stenosis specialists. Doctors such as Dr. Sumit Kapadia, who specialise in Carotid Artery Disease, have years of experience in performing delicate surgeries like carotid endarterectomy and carotid angioplasty. Their expertise and track record of successful surgeries attract patients from around the world.

Affordable Treatment Options The cost of treatment in India is a fraction of what you would pay in developed countries. Whether it's carotid artery blockage treatment or a carotid artery Doppler test, you can expect to save up to 60-70% on medical bills. This affordability, combined with the high standard of care, makes India an attractive destination for those seeking treatment for Carotid Artery Disease.

Comprehensive Care Packages Many Indian hospitals offer comprehensive care packages that cover everything from diagnostic tests to surgery and follow-up care. These packages are designed to make the treatment process smooth, reducing the overall cost and providing a transparent pricing structure.

Shorter Waiting Times Unlike many Western countries where long waiting times for surgeries are common, India offers quick access to treatment. Once you are diagnosed with carotid artery stenosis, you can expect to be treated promptly, allowing you to avoid the risk of complications like stroke.

Benefits of Treatment Under Dr. Sumit Kapadia

Dr. Sumit Kapadia is one of the leading vascular specialists in the region, known for his expertise in treating carotid artery stenosis and other vascular diseases. Choosing Dr. Kapadia for your treatment offers several benefits:

Extensive Experience With years of experience in diagnosing and treating Carotid Artery Disease, Dr. Kapadia has helped many patients regain their health and avoid stroke. His expertise in carotid artery blockage and related conditions ensures that you are in safe hands.

Advanced Treatment Options Dr. Kapadia stays at the forefront of medical advancements, offering the latest treatments and techniques for carotid artery stenosis. His use of minimally invasive procedures like carotid angioplasty ensures faster recovery times and fewer complications.

Personalised Care Dr. Kapadia takes a personalised approach to each patient, ensuring that the treatment plan is tailored to your specific needs. Whether you require carotid artery blockage treatment or a simpler procedure, he ensures that every step of the process is handled with the utmost care and attention.

Recovery and Post-Treatment Care

After undergoing treatment for carotid artery stenosis, it’s essential to follow a structured recovery plan. Recovery time varies depending on the type of treatment received:

Post-Surgery Care For those who have undergone carotid endarterectomy or carotid angioplasty, the hospital stay typically lasts for 2-4 days. After discharge, patients are advised to avoid strenuous activities for a few weeks. Regular follow-up visits are scheduled to monitor progress and ensure that the artery remains open.

Medications Patients may need to take medications such as blood thinners to prevent clot formation and control cholesterol levels. It’s essential to follow the doctor’s instructions regarding medication to ensure the success of the treatment.

Lifestyle Modifications Adopting a healthy lifestyle, including a balanced diet, regular exercise, and smoking cessation, is critical for long-term recovery and preventing recurrence of Carotid Artery Disease.

Conclusion

Carotid artery stenosis treatment in India offers a comprehensive solution at a fraction of the cost you would incur in other countries. The availability of world-class medical facilities, experienced specialists like Dr. Sumit Kapadia, and affordable treatment options make India an ideal destination for those seeking carotid artery blockage treatment. Whether it’s through carotid angioplasty, carotid endarterectomy, or the necessary pre-treatment diagnostic tests like the carotid Doppler test, you can expect top-notch care and successful outcomes. With the right treatment, the risks associated with Carotid Artery Disease can be managed effectively, ensuring a healthier future.

#carotid artery stenosis treatment cost #carotid artery blockage treatment #carotid artery blockage #carotid artery stenosis #carotid artery stenosis symptoms #Carotid Artery Disease #vein specialist doctor near me

0 notes

healthpackageservicesatultrascan · 3 days ago

Text

Importance of the Renal Doppler Test in Kidney Health

Kidney health is an essential component of overall well-being, as the kidneys perform critical functions such as filtering waste, maintaining fluid balance, and regulating blood pressure. The Renal Doppler Test is a specialized diagnostic tool that assesses blood flow in the renal arteries and veins. For those looking for a quality diagnostic centre in Indore, understanding the role of a renal Doppler test in Indore can help safeguard kidney health through early diagnosis and treatment.

What is a Renal Doppler Test?

A Renal Doppler Test is a non-invasive ultrasound procedure designed to evaluate blood flow to and from the kidneys. By using Doppler ultrasound technology, this test detects abnormalities such as blockages, narrowing of arteries (stenosis), and other vascular issues that may impact kidney function. Patients searching for a Doppler test near me or affordable Doppler scan prices can benefit from this effective diagnostic tool.

Why is the Renal Doppler Test Important for Kidney Health?

1. Early Detection of Kidney Disorders

The Renal Doppler Test can identify vascular issues like renal artery stenosis, a leading cause of secondary hypertension. Early detection allows for timely intervention, preventing further complications.

2. Evaluation of High Blood Pressure Causes

For patients with persistent or resistant hypertension, the test helps identify vascular contributions, enabling targeted treatments.

3. Monitoring Chronic Kidney Disease

This test is essential for patients with chronic kidney disease (CKD), as it provides insights into how well the kidneys are receiving and processing blood flow.

4. Safe and Non-Invasive

Unlike invasive tests, the Renal Doppler is a painless, non-invasive procedure that uses sound waves to generate images, making it safe for patients of all ages.

How is the Renal Doppler Test Performed?

The Renal Doppler Test is simple and efficient:

Preparation: Patients may be asked to fast for 6-8 hours to reduce interference from bowel gas.

Procedure: A gel is applied to the abdominal area, and a handheld transducer emits sound waves to capture images of the renal arteries and veins.

Duration: The test usually takes 30-45 minutes, with results available shortly after.

If you're looking for a Doppler scan near me, Ultrascan Diagnostics in Indore offers advanced imaging facilities with experienced professionals to ensure accurate results.

Conditions Diagnosed by the Renal Doppler Test

Renal Artery Stenosis: A narrowing of the renal arteries that can cause hypertension and kidney failure.

Thrombosis: Blood clots in the renal veins that obstruct blood flow.

Aneurysms: Bulging or weakening of blood vessel walls in the renal arteries.

Kidney Transplant Evaluation: Assessment of blood flow in transplanted kidneys.

Complementary Doppler Tests

Carotid Doppler Test: Evaluates blood flow in the carotid arteries to prevent stroke.

Penile Doppler Test: Assesses blood flow in the penile arteries, often used for erectile dysfunction diagnosis.

Fetal Doppler Scan: Monitors blood flow and oxygen delivery to the fetus during pregnancy.

Colour Doppler Test for Legs: Detects vascular issues such as deep vein thrombosis or varicose veins.

Each of these tests, including the renal artery Doppler, offers detailed insights into specific vascular conditions, ensuring comprehensive care.

Affordability and Access

For patients concerned about Doppler scan prices, Ultrascan Diagnostics provides cost-effective solutions without compromising on quality. The center specializes in a variety of Doppler tests, including renal Doppler tests, colour Doppler ultrasounds in pregnancy, and more, with transparent pricing and compassionate care.

FAQs About Renal Doppler Test

1. What is the purpose of a Renal Doppler Test?

The Renal Doppler Test evaluates blood flow in the renal arteries and veins, helping to diagnose conditions like renal artery stenosis, thrombosis, and kidney dysfunction. It’s also used to monitor kidney health in patients with chronic diseases.

2. Are there any risks associated with the Renal Doppler Test?

No, the Renal Doppler Test is a non-invasive and safe procedure. It does not involve radiation or contrast dyes, making it suitable even for patients with kidney concerns or allergies.

3. How should I prepare for a Renal Doppler Test?

Patients are typically advised to fast for 6-8 hours before the test to minimize interference from bowel gas. Wearing comfortable clothing and following any specific instructions provided by the diagnostic center is also recommended.

Conclusion

The Renal Doppler Test is an invaluable tool for diagnosing and managing kidney-related vascular issues. Its ability to provide accurate, non-invasive insights into blood flow makes it a cornerstone of kidney health diagnostics.

If you’re searching for a renal Doppler test in Indore, Doppler test near me, or a reliable quality diagnostic centre in Indore, Ultrascan Diagnostics offers state-of-the-art technology and expert care. Contact Ultrascan Diagnostics today to take a proactive step toward better kidney health.

Contact Details [email protected] Mon to Sat : 08:00 AM to 08:00 PM +91 78695 24599 451-G Greater Brajeshwari,Near Kerala Bakery,Pipliyahana Road, Pipliyahana, indore, Madhya Pradesh 452016

#diagnostic ultrasound #doppler #diagnosticprocess

0 notes

futuristicpaintercat · 4 months ago

Text

Neuro-interventional Devices Market is Estimated to Witness High Growth Owing to Increasing Prevalence of Neurovascular and Neurological Disorders

The neuro-interventional devices market comprises devices that include embolic coils, flow diverters, distal access catheters, liquid embolics, coil assist stents, micro-catheters, balloon guiding catheters, neurovascular stents, and stent retrievers. These devices are used for the diagnosis and treatment of neurovascular and neurological disorders including cerebral aneurysm, carotid artery stenosis, arteriovenous malformation, and ischemic stroke. The increasing number of patients suffering from these disorders has boosted the demand for advanced neuro-interventional devices.

The Global neuro-interventional devices market is estimated to be valued at US$ 2.7 Bn in 2024 and is expected to exhibit a CAGR of 5.0% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the neuro-interventional devices are Penumbra, Inc., Stryker Corporation, Medtronic PLC., Johnson and Johnson Services, Inc., Terumo Corporation, Insera Therapeutics Inc., Anaconda Biomed S.L., NeuroVasc Technologies and Perflow Medical Ltd. These players are focusing on new product launches and geographic expansions to strengthen their market position. Some of the key opportunities in the market include growing preference for minimally invasive surgeries and the untapped potential in emerging economies. The increasing healthcare expenditure and growing demand for advanced medical technologies in countries such as China, India, Brazil, and Mexico will support the market growth. The rising medical tourism in Asian and Latin American countries also offers opportunities for manufacturers. These regions offer neuro-interventional surgeries at affordable costs as compared to developed nations in North America and Western Europe. Market Drivers The increasing prevalence of neurovascular and neurological disorders is one of the key drivers of the Neuro-Interventional Devices Market Share. According to estimates, nearly one-fourth of the population is likely to suffer a stroke during their lifetime. The growing number of ischemic strokes owing to changing lifestyle habits will eventually increase the demand for neurological devices. Advanced neuro-interventional devices are more effective and safer as compared to traditional open surgery which involves risks of infection, blood loss, and long recovery time. The advantages offered by minimally invasive endovascular procedures in reducing complications are expected to contribute to the high growth of the neuro-interventional devices market during the forecast period.

PEST Analysis Political: Government policies and regulations play a major role in determining the growth of the neuro-interventional devices market. Regulations on approval, adoption and reimbursement of new devices shape industry developments. Economic: Economic growth, rise in healthcare spending and increasing disposable income have positively impacted market growth over the last few years. However, the current economic slowdown caused by COVID-19 pandemic poses short term challenges. Social: Rising geriatric population and incidence of neurological disorders like stroke, aneurysm, arteriovenous malformation drives demand for neuro-interventional devices. Higher awareness and access to sophisticated treatment methods fuels adoption. Technological: Advancements in design, material and manufacturing improve effectiveness and reduce risks of procedures. Developments in 3D printing, navigation systems and bioabsorbable materials support new product innovations. Continued R&D lead to improved patient care. The North American region currently holds the largest share of the neuro-interventional devices market in terms of value. High healthcare spending, availability of advanced healthcare facilities, and favorable reimbursement policies are key factors supporting market growth in this region. The Asia Pacific region is anticipated to grow at the fastest rate over the forecast period. Rapidly developing healthcare infrastructure, increasing healthcare expenditure, rising incidence of brain disorders and growing demand for minimally invasive surgical techniques are driving the neuro-interventional devices market in Asia Pacific region. Countries like India, China and Japan are expected to provide lucrative opportunities.

Get more insights on Neuro-interventional Devices Market

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

0 notes

neurologist23 · 9 months ago

Text

5 Best Neurologist in Delhi

Dr Manvir Bhatia

Dr. Manvir Bhatia is best neurologist in Delhi & best sleep specialist in India and has great expertise knowledge in the field of neurology and sleep disorder, at Neurology Sleep Centre has world-class Neurology and sleep Services available for in clinic . Dr.Manvir is Director of Sleep medicine and senior Neurologist at Fortis Escorts Heart Institute-New Delhi and Neurology Sleep Centre, New Delhi. She is currently the Vice President of Indian society of Sleep research. She is the author of the book “The Sleep Solution” first non-fiction book on sleep, in India.

She was invited by the WHO to participate in developing guidelines for health issues related to ‘Sleep��. She has been awarded the Indira Gandhi Mahila Ratan Award & has won the best prize for “10,000 women Entrepreneur Certificate Programmed at ISB”, Hyderabad. She has also been awarded by AAPIOS (American Association of Physicians of Indian Origin, Boston, for “Extraordinary Contribution in Sleep Medicine” for the year 2017, for increasing the awareness of sleep medicine throughout, research and training of sleep experts in India.

MEDICAL QUALIFICATION: Medical school: Christian Medical College and Hospital, Ludhiana DM Neurology: AIIMS, New Delhi Past Positions- Additional Professor and Incharge of Neuro-Electrophysiology, Sleep Medicine at AIIMS, New Delhi. Chairperson Sleep Medicine, Senior Neurology Consultant at Sir Ganga Ram Hospital, New Delhi. Senior Visiting Consultant, Neurologist & Sleep Medicine, Medanta The Medicity, Gurgaon, Senior Consultant & Director- Sleep Medicine in Saket City Hospital, New Delhi.

LOCATION : L-23, Hauz Khas Enclave, New Delhi 110016 (INDIA)

Dr. Vinit Banga

Dr. Vinit Banga is a Neurologist in Pusa Road, Delhi and has an experience of 12 years in this field. Dr. Vinit Banga practices at BLK-Max Super Speciality Hospital in Pusa Road, Delhi. He completed MBBS from Ch. Charan Singh University, Meerut in 2019,MD - General Medicine from Bundelkhand University, Jhansi in 2012 and DM - Neurology from Delhi University in 2016.

He is a member of Indian Medical Association (IMA). Some of the services provided by the doctor are: Foot Drop,Brain Aneursym Surgery,Sciatica Pain Treatment,Spinal Tap and Brain Surgery etc

MEDICAL QUALIFICATION: MBBS, MD - General Medicine, DM - Neurology

3.Dr. Shailesh Jain

Dr Shailesh Jain is a renowned Neurosurgeon and Stroke Interventionist has been performing Minimal Invasive Neuro & Spine Surgeries for past 16 years with excellent results. He has vast experience and has been a pioneer in treatment of Brain & Spine diseases such as fits ,headaches, cervical n lower back pain, brain n spine Timor’s

He specializes interventional treatment in stroke such as Intracranial aneurysms embolization (coiling), ArterioVenous malformation (AVMs) embolization, tumour embolization, Angioplasty and stenting of arterial stenosis including carotid stenting, Intra-arterial Thrombolysis for stroke and Percutaneous spinal procedures such as vertebroplasty and other interventional procedures.

Dr. Shailesh Jain is Principal Consultant Neurosurgery & Neurointervention at Max Hospital Shalimar Bagh.

His compassion, strong work ethics, professionalism, knowledge, confidence, humility and passion towards dealing with neurosurgical patients makes him a good human being and a superior clinician.

MEDICAL QUALIFICATION : MBBS, MS - General Surgery, MCh - Neuro Surgery

Neurosurgeon,Neurointerventional Surgery,Neurologist

4.Dr. Rajiv Anand

Dr. Rajiv Anand Neurologist with a passion for making a difference in the care of a patient with neurological disorders. Always looking out for accuracy in clinical diagnosis and treatments. Focuses on treatable neurological disorders and cost-effective therapies in neurology. Medical knowledge is continuously evolving, therefore, he spends significant time in learning through updates and from each and every patient he sees in his practice. He also acquiring soft skills to comfort his patients.

MEDICAL QUALIFICATION: MBBS, MD - Medicine, DM - Neurology

5. Dr. Ramandeep S. Dang

Prof. (Dr.) Ramandeep S. Dang is a Senior Consultant, Neurosurgeon and Pain Specialist (Brain and Spine Surgeon) in South Delhi. He is attached to Moolchand Medicity, Lajpat Nagar, Sama Hospital, New delhi, Cronus Hospital Chattarpur. and Onco plus hospital, defence colony New delhi. Specialises in Minimally Invasive and endoscopic Brain Spine and Pain reliving procedures especially for disc problem, back pain,cervical , headaches , trigeminal neuralgia, sciatica, spine fractures. These procedures are day care procedures and patients are usually sent home the same day. Non clinic hour confirmation only after telephonic confirmation .

MEDICAL QUALIFICATION: MBBS, MS - General Surgery, MCh - Neuro Surgery

Neurosurgeon,Neurologist,Spine Surgeon (Neuro),Spine And Pain Specialist

#best neurologist in delhi #neurology doctor in delhi #sleep apnea treatment

0 notes

phoenix-ultrasound · 1 year ago

Link

#DVTDoppler #DVTDopplerUltrasound #Vascularscans

0 notes

mcatmemoranda · 5 years ago

Text

Stroke is the third leading cause of death in the United States following heart disease and cancer-related deaths. The clinical definition of a stroke is the sudden loss of blood flow to a portion of the brain leading to ischemia and resulting in a related permaneant loss of neurological function. This is typically manifested as either weakness, difficulty with speech or a sensory loss. Although not a treatment for a stroke, carotid endarterectomy is performed to reduce the risk of a subsequent stroke when a patient has had a TIA or nondisabling stroke and is found to have significant carotid stenosis on the side corresponding to the cerebral event.

Recent randomized prospective clinical trials have shown that carotid endarterectomy is the treatment of choice compared with medical therapy for a given group of patients. Three recent trials on carotid endarterectomy: the North American Symptomatic Carotid Endarterectomy Trial (NASCET), the European Carotid Surgery Trial (ECST), and the Veterans Affairs Trial of Carotid Endarterectomy in Symptomatic Carotid Stenosis showed that when acceptably low surgical morbidity and mortality are achieved, carotid endarterectomy improves outcome in symptomatic patients with severe carotid stenosis of 70%-99%. In fact, carotid endarterectomy is three times as effective as medical therapy alone in reducing incidence of stroke in patients with symptomatic stenosis of 70% to 99%. It is important to realize, however, that carotid endarterectomy itself has both intraoperative and postoperative risks. Even with a low surgical risk carotid endarterectomy only provides a modest benefit in symptomatic patients with carotid artery stenosis of 50 to 69 percent. In symptomatic patients with less than 50% stenosis platelet antiaggregants and risk factor modification are recommended. The complication rate after carotid endarterectomy should be maintained at an extremely low rate ( 3%) by surgeons to keep the beneficial effects of carotid endarterectomy over medical therapy .

Overall, carotid endarterectomy is beneficial for symptomatic patients with recent nondisabling strokes and carotid artery stenosis ranging from 70% to 99% . Carotid endarterectomy is not beneficial for symptomatic patients with 0% to 29% stenosis . Uncertainty about the potential benefit of carotid endarterectomy for symptomatic patients with 30% to 69% stenosis remains. Currently based on the available data from the ECST study, results do not support surgery for patients with <50% stenosis. In summary, timely and low risk surgical intervention reduces the risk of recurrent cerebral ischemia or death from stroke in patients with TIAs or nondisabling strokes within the previous six months that were associated with diameter-reducing carotid stenosis of 70%-99% (1).

Source: http://d3tfb844wwci5y.cloudfront.net/assets/carotid/html/h05.html

Atherosclerotic plaques can cause transient ischemic attacks (TIAs) and strokes by generating emboli that can travel to distal vessels supplying the brain. A number of medical measures can be used to manage carotid artery stenosis, which include treating risk factors such as hypertension, hypercholesterolemia, and smoking, educating patients about TIA symptoms, and antiplatelet therapy. Antiplatelet medications probably reduce stroke by reducing the risk of arteriogenic clot formation on thrombogenic surfaces of atherosclerotic plaques (1). These medications include aspirin, ticlopidine (Ticlid), as well as newer drugs clopidogrel (Plavix) and high-dose dipyridamole (Persantine).

Aspirin has repeatedly been demonstrated as an inferior treatment of carotid stenosis, compared to surgical endarterectomy. Nonetheless, it reduces the incidence of stroke by about 25%, which means that 50 patients must be treated for one year to prevent one stroke. The current FDA-recommended aspirin dosage for stroke prevention is between 50 and 325 mg per day (1). Ticlopidine is appreciably more effective than aspirin in stroke prevention in patients with TIA or minor ischemic stroke. However, its potential side effects, including leukopenia, skin rash and diarrhea, as well as its higher cost, cause most physicians to prescribe ticlopidine only to aspirin-intolerant patients and those who continue experiencing cerebral ischemia while taking aspirin. Clopidogrel was recently found to be statistically significantly more effective than aspirin in preventing stroke, myocardial infarction and vascular death as a result of an international mega-trial with over 19,000 participants with various manifestations of vascular disease (1). In addition, the side effect profile of clopidogrel was similar to that of aspirin, without an increase in leukopenia. Therapy with high-dose dipyridamole plus aspirin has recently been shown to be better than aspirin alone, with a 21% risk reduction relative to aspirin. A major side effect of high-dose dipyridamole is headache and its role for prevention of stroke in patients with cerebrovascular disease remains controversial (1).

The superiority of surgical treatment of symptomatic carotid disease in patients with carotid stenosis of 70% and higher has been shown in three major studies (2).

They showed that carotid endarterectomy, a surgical procedure which removes atherosclerotic plaques from the carotid arteries and restores unobstructed blood flow to the brain, improves stroke-free survival in high risk symptomatic patients. The first published study was the North American Symptomatic Carotid Endarterectomy Trial (NASCET), which established carotid endarterectomy to be highly beneficial to patients with recent hemispheric or retinal transient ischemic attacks or minor strokes who had ipsilateral internal carotid artery stenosis of >=70% measured by arteriogram. Specifically, one of the findings of NASCET was an absolute risk reduction of 17% in ipsilateral stroke at two years after the operation in 659 patients followed in the trial (3). When all strokes and deaths were included in the analysis, carotid endarterectomy was still statistically significantly beneficial (3). A similar study in Europe (European Carotid Surgery Trial, or ECST) demonstrated superiority of carotid endarterectomy compared with medical therapy in 778 patients with similar characteristics (4). Finally, the Veterans Affairs Trial of Carotid Endarterectomy in Symptomatic Carotid Stenosis, which was terminated after the positive results of NASCET and ECST became known, also showed benefit in some patients with high-grade symptomatic carotid artery stenosis (5).

Source: http://d3tfb844wwci5y.cloudfront.net/assets/carotid/html/h06.html

Two major randomized controlled trials have shown significant benefits of carotid endarterectomy in lowering the risk of stroke in patients with severe symptomatic carotid stenosis compared with best medical treatment (1,2). NASCET showed no benefit in patients with 30-49% stenosis, and a small benefit in those with 50-69% stenosis (2). ECST demonstrated that the procedure was harmful in patients with less than 70% stenosis (1). Both trials showed clear significant improvement in outcome in patients with 70 and higher percent stenosis (1,2). However, the NASCET method underestimated the degree of carotid stenosis relative to the ECST method owing to a different technique of measuring stenosis on angiogram; therefore, taken together the two trials established endarterectomy to be beneficial in patients with symptomatic stenosis of 70% or more by the ECST method (3).

This general conclusion is of little value in taking care of individual patients who may have other clinical characteristics affecting their risk of stoke besides the degree of carotid stenosis (3).

If all groups are combined, only 20% of patients in whom carotid endarterectomy prevents stroke would have a major stroke on medical treatment alone; the other 80% of these patients would not suffer a stroke when treated medically, making the operation of no value in these patients and exposing them to the morbidity and mortality associated with surgery (3). When deciding whether an individual patient would benefit from the operation, the risk of stroke without surgery must be balanced with the risk of stroke and death resulting from surgery by taking into consideration all of the patient’s characteristics. For example, in addition to the degree of symptomatic carotid stenosis, the qualities of the vascular plaque and the type of the recent ischemic symptom (cerebral vs. ophthalmic) influence the risk of stroke (3). The risk of stroke and death from carotid endarterectomy has been found to be increased in patients who: experience a recent cerebral ischemic event as opposed to ocular ischemia alone; are women; have systolic blood pressure over 180 mm Hg; have peripheral vascular disease; are found to have contralateral internal carotid artery occlusion, ipsilateral internal carotid siphon stenosis, or ipsilateral external carotid artery stenosis (4). This risk is not significantly affected by the patient having diabetes or angina, recent myocardial infarction, current cigarette smoking, irregularity of the carotid plaque, or whether the patient presented with a cerebral TIA versus stroke (4). All of these factors should be taken into consideration on a case-by-case basis before performing carotid endarterectomy.

One of the investigators in the ECST Dr. Peter Rothwell and his colleagues developed a prognostic scoring system to identify candidates for operative treatment of carotid stenosis, i.e. those with a high risk of stroke with medical treatment alone and a low operative risk (3). They categorized 990 patients with symptomatic carotid stenosis of 70% or higher based on seven independent prognostic factors (similar to the factors mentioned above). They found that only 16% of the subjects benefited from surgical intervention, with the 5-year risk of ipsilateral major ischemic stroke, operative stroke, or death lessened by 33% in the 16% of patients with a score of 4 or more (3). However, further refinement of their scoring system may be necessary (3).

Source: http://d3tfb844wwci5y.cloudfront.net/assets/carotid/html/h07.html

#CEA #carotid endarterectomy #stroke #NASCET #ECST

2 notes · View notes

industryarcmarketresearch · 3 years ago

Text

Neurovascular Stent Market Size Forecast to Reach $4.3 Billion by 2026

Neurovascular Stent Market size is forecast to reach $4.3 billion by 2026, growing at a CAGR of 6.2% during the forecast period 2021-2026. A neurovascular stents is made of metal or polymer and is utilized to treat stenosis formation and ischemic stroke in the blood vessels. It is used for thrombectomy owing to their ability to rapidly restore the blood flow in the embolic stroke. Ischemic stroke, atherosclerosis, and aneurysms are some of the major cause that leads to disability and death. High incidence rates of cerebral disorders & brain aneurysm, technological advancement in healthcare industry, and growth in unhealthy diet are the major factors driving the growth of the market. Excessive consumption, smoking, less physical activity, stress, and increasing demand for minimally invasive procedures is set to further enhance the overall market development of the Neurovascular Stent Market for the period 2021-2026.

Neurovascular Stent Market Segment Analysis – By Product Type

Carotid Artery Stent held the largest share in the Neurovascular Stent Market in 2020 and is estimated to grow at a CAGR 5.8% during the forecast period 2021-2026. This is attributed to the rise in incidence and prevalence of brain and cerebral aneurysm. A carotid artery stent is a hollow, long tube that is passed through the arteries to the narrowed carotid artery in the neck. A stent is inserted into the carotid artery after angioplasty that uses a balloon inflated in the narrowed part of the artery. Carotid artery stents remains permanently in the artery and usually takes about 1 to 2 hours. Intracranial stents require adequate dual antiplatelet therapy and are also thrombogenic. Additionally, increase in technologically advanced neurovascular stents is increasing the demand of intracranial stents. Intracranial stents are estimated to register the highest CAGR over the period 2021-2026.

Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=507042

Report Price: $ 5900 (Single User License)

Neurovascular Stent Market Segment Analysis – By End Users

Hospital held the largest share in the Neurovascular Stent Market in 2020 and is estimated to grow at a CAGR 5.7% during the forecast period 2021-2026. This is attributed to the fact that it offers minimally invasive procedures for various diseases along with the high end technological products. Favorable reimbursement policies for hospital procedures and improvements in healthcare facilities are increasing the demand of neurovascular stents in hospitals. Ambulatory surgical units offer cost effective and quality treatments that drive the patient’s preference for surgical procedures being performed in the ambulatory surgical centers. Ambulatory Surgical Units are estimated to register the highest CAGR over the period 2021-2026.

Neurovascular Stent Market Segment Analysis – By Geography

North America dominated the Neurovascular Stent Market with a major share of 38.1% in 2020. This is attributed to the high prevalence of cerebral disorders such as malformation & Stenosis and increase in acceptance of minimally invasive procedure to treat neurovascular diseases. Increasing government initiative to modernize healthcare infrastructure and accessibility to technologically advanced medical treatments and products is also increasing the growth of the market in this region. However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to the rising awareness regarding advanced and innovative neurovascular devices. Large patient pool and rising healthcare expenditure is also increasing the growth of the market in this region.

Neurovascular Stent Market Drivers

Increasing Number of Ischemic Strokes and Aneurysm patients

Increasing number of brain aneurysm and ischemic strokes and brain aneurysm patients is increasing the growth of the Neurovascular Stent Market. Ischemic stroke occurs when the ruptured blood vessel in the brain has been blocked and weakened artery wall causes aneurysm that can ruptures and subsequently bleed while affecting the brain and the heart. Increasing investment in research activities to develop technologically advanced devices for treating acute ischemic stroke along with increasing healthcare expenditure is increasing the growth of the market. In U.S., about 35,000 people suffer a brain aneurysm each year. Thus, increasing the growth of the Neurovascular Stent Market during the forecast period 2021-2026.

Rising Demand for Minimally Invasive Surgical Procedures

Rising demand for minimally invasive surgical procedures is increasing the growth of the Neurovascular Stent Market. Minimally invasive surgical procedure is used to treat problems that affects the blood vessels such as an aneurysm. It requires a small incision that is performed within the artery through a catheter. The catheter is inserted into the blood stream and guided to the brain. It results in less pain, less risk of complication than open surgery, and also shorter hospital stays. Minimally invasive surgical procedures includes angioplasty, embolization, stenting, and coiling which are much better than the traditional open surgery method. Thus, increasing the growth of the Neurovascular Stent Market during the forecast period 2021-2026.

Download Sample Report @ https://www.industryarc.com/pdfdownload.php?id=507042

Neurovascular Stent Market Challenges

High Product Cost and Complications Associated With Neurovascular Stents

Some of the factors that are set to impede the growth of the Neurovascular Stent Market are high product cost and complications associated with neurovascular stents. Challenges involved in commercialization of neurovascular devices is also set to hamper the growth of the market.

Neurovascular Stent Market Landscape

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Neurovascular Stent Market. In 2020, the Neurovascular Stent Market share is consolidated by the top ten players present in the market. The Neurovascular Stent Market, top 10 companies are Boston Scientific, Integer, Micro Point Scientific, Medtronic, Stryker, Tarumom, Cordis, Acandis, Johnson & Johnson, and Gore Medical among others.

Key Takeaways

North America dominated the Neurovascular Stent Market in 2020 owing to the high prevalence of cerebral disorders such as malformation, brain aneurysm, & stenosis, and increase in adoption of minimally invasive procedure to treat neurovascular diseases. The Neurovascular Stent Market scope for different regions will be provided in the final report.

Rising emergence of neurovascular stent with advanced technology and awareness programs are likely to aid the market growth of the Neurovascular Stent Market report.

Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Neurovascular Stent Market report.

High product cost and complications associated with neurovascular stents procedure is poised to create the hurdles for the Neurovascular Stent Market.

Related Reports:

A. Stents Market

https://www.industryarc.com/Report/16967/stents-market.html

B. Neurovascular Stent Retrievers Market

https://www.industryarc.com/Research/Neurovascular-Stent-Retrievers-Market-Research-507011

For more Lifesciences and Healthcare Market reports, please click here

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.

#NeurovascularStentMarket #NeurovascularStentMarketshare

0 notes

healthcare-market · 3 years ago

Text

Flow Diverters Market : Latest Innovations, Future Scope and Market Trends

Advancement in scientific technology has led to development of new generation stents referred as flow diverters. Flow diverters stenting has become the most widely accepted minimally invasive method for treatment of intracranial aneurysm. Flow diverters cause the disruption of intra-aneurysmal blood flow which results in change of the transmural pressure gradient. Interventional cardiologists, surgeons, neurologists, and radiologists are efficient in performing this procedure. Usage of endovascular stents has increased due to growing acceptance of flow diverters by surgeons and physicians. This procedure is highly recommended by health care centers and hospitals worldwide to people with carotid artery stenosis. Also, several vendors are focusing on getting clinical data and findings that support the adoption of flow diverters, which will enable manufacturers and researchers to develop new technologies for treating intracranial aneurysm. Rise in demand for minimally invasive endovascular surgeries is projected to contribute to the growth of the global flow diverters market during the forecast period.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=32300

The first clinical use of a flow diverter in North America was reported in 2008. The use of flow diverter has widened the scope of treatment of cerebral aneurysms. Flow diverters have helped in treating previously untreatable intracranial aneurysms. Increase in cases of brain aneurysms drive the global flow diverters market. Moreover, growing awareness and demand for minimally invasive endovascular surgeries propel the market. However, complications associated with the procedure, high cost of treatment, and alternative procedures and therapies restrain the global flow diverters market.

Request for Analysis of COVID19 Impact on Flow Diverters Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=32300

Flow diverters are available in different lengths, diameter sizes, materials, and designs. The global flow diverters market can be segmented based on device type, end-user, and region. In terms of device type, the market can be categorized into Pipeline embolization device (PED), Silk flow diverter (SILK), Surpass flow diverter (SURPASS), FRED flow diverter, and p64 flow diverter. Cobalt-chromium and platinum-tungsten materials are used in the manufacture of flow diverters. PED is the most commonly used flow diverter in treatment of intracranial aneurysms. It is made of 75% cobalt-nickel and 25% chromium-platinum alloy and consists of a stent-like device with porosity of 65% to 70%. These are available in 2.5 mm to 5 mm diameter and 10 mm to 35 mm length. Silk flow diverters are currently unavailable for use in the U.S. and limited data is available on the use of Surpass flow diverter. Based on end-user, the global flow diverters market can be classified into hospitals and research institutes. Adoption of flow diverters for the treatment of intracranial aneurysms by neurosurgeons and physicians has fueled the growth of the global flow diverters market in the past few years.

Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=32300

In terms of region, the global flow diverters market can be segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America dominates the global flow diverters market because of fast growing life science industry, rising focus on research & new technology development. Europe is the second largest market for flow diverters. Asia Pacific is projected to be the most lucrative market for flow diverters and is expected to expand at the highest growth rate from 2017 to 2025. Rise in government initiatives, grants, and funds; increase in life science R&D spending especially in India, China, and Japan, and dedicated research commercial zones are attracting domestic and foreign players to invest and enter the lucrative research sector in Asia Pacific.

Pre-book Flow Diverters Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=32300&ltype=S

Key players operating in the global flow diverters market are Medtronic, Balt Extrusion, MicroVention, Inc., and Stryker, among others.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/presence-of-large-insulin-dependent-diabetic-population-expand-avenue-in-self-injection-device-market-pen-injectors-to-account-for-sizable-revenue-share-says-tmr-301260639.html

https://www.prnewswire.com/news-releases/overwhelming-cases-of-drug-driving-accidents-underscores-growth-in-roadside-drug-testing-devices-market-authorities-consider-use-of-technology-to-support-testing-tmr-301266637.html

https://www.prnewswire.com/news-releases/technological-advancements-like-3d-printing-and-an-increase-in-the-number-of-amputations-due-to-various-factors-will-serve-as-growth-pillars-for-the-prosthetics-market-says-tmr-301271549.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Transparency Market Research 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com/

0 notes

adityarana1687-blog · 4 years ago

Text

Neurovascular Devices Market Is Expected To Accomplish A Valuation Of Around $4.12 Billion By 2027

The global neurovascular devices market size is anticipated to reach USD 4.12 billion by 2027, registering a CAGR of 4.3% over the forecast period, according to a new report by Grand View Research, Inc. Rising demand for minimally invasive procedures, increasing incidence of neurological disorders, and introduction of technologically advanced products are driving the growth of neurovascular devices.

Increasing incidence of neurological conditions such as stroke and brain aneurysm, cerebral artery stenosis, and stroke are fueling the market growth. For instance, according to the Stroke Association, more than 100,000 people suffer from stroke every year in U.K. and stroke costs are up to USD 33.7 billion per year.

Decreased postoperative pain and speedy recovery are leading to increasing adoption of minimally invasive surgeries and triggering growth of R&D in this field. Several key players are investing in R&D for the launch of innovative minimally invasive surgical instruments, especially got the neurovascular diseases. The endovascular coiling used for the treatment of intracranial aneurysm is one of the minimally invasive procedures widely recommended by the physicians.

Furthermore, increasing number of technologically advanced product launches by the key market players are also contributing to the market growth. For instance, in January 2018, CERENOVUS, launched Galaxy G3 mini coil, the softest and smallest embolic finishing coil used in the treatment of hemorrhagic stroke and intracranial aneurysm.

Request a free sample copy or view report summary: Neurovascular Devices Market Report

Neurovascular Devices Market Report Highlights

The cerebral embolization and aneurysm coiling devices segment dominated the neurovascular devices market in 2019 owing to increasing demand for minimally invasive procedures and rising incidence of cerebral artery stenosis

Based on therapeutic application, the stroke segment dominated the market in 2019 owing to increasing prevalence of stroke worldwide, awareness initiatives by various government and non-government organizations, and introduction of technologically advanced products

North America dominated the market with the highest revenue share in 2019 owing to increasing prevalence of stroke and brain aneurysm, increasing disposable income, and presence of key players in the region

Some of the major players operating in the market are Medtronic; Microport Scientific Corporation; Penumbra, Inc.; Stryker; Johnson and Johnson Services Inc.; Microvention Inc.; and Codman Neuro

Neurovascular Devices Market Segmentation

Grand View Research has segmented the global neurovascular devices market on the basis of device, therapeutic application, and regions:

Neurovascular Devices Outlook (Revenue, USD Million, 2016 - 2027)

Cerebral Embolization and Aneurysm Coiling Devices

Cerebral Angioplasty and Stenting Systems

Neurothrombectomy Devices

Support Devices

Embolic Coils

Flow Diverters

Liquid Embolic Agents

Carotid Artery Stents

Embolic Protection

Clot Retrieval

Suction

Vascular Snares

Micro Catheters

Micro Guidewires

Neurovascular Devices Therapeutic Application Outlook (Revenue, USD Million, 2016 - 2027)

Stroke

Cerebral Artery Stenosis

Cerebral Aneurysm

Others

Neurovascular Devices Regional Outlook (Revenue, USD Million, 2016 - 2027)

North America

Europe

Asia Pacific

Latin America

Middle East and Africa (MEA)

U.S.

Canada

U.K.

Germany

France

Italy

Spain

Japan

China

India

Australia

South Korea

Mexico

Brazil

Argentina

Colombia

South Africa

Saudi Arabia

UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

#Neurovascular Devices Market

0 notes

adwaitcoherent · 4 years ago

Text

By 2026, Intracranial Stents Market To Surpass US$ 1,143.0 Million - Coherent Market Insights

Intracranial Stents Market To exhibit a CAGR of 15.6% over the forecast period (2018 - 2026).

Request for Sample PDF Copy:

https://www.coherentmarketinsights.com/insight/request-pdf/1870

Description:

Narrowing of the blood vessels or blood clots due to building up of fats, plaque, and other substances in the blood vessels is called intracranial stenosis. This condition marks with a stroke either to the carotid artery in the neck or in an intracranial artery. Stents during this condition act as a permanent implant which allows blood flow to the brain by opening the blocked arteries. Angioplasty (use of balloon catheter) along with placement of a stent may be an appropriate treatment for the patients who have had a stroke or transient ischemic attack (TIA). However, since these stents are designed for use in the heart, it is complex to use them in the arteries of the brain. Though, with the advent of the new self-expanding brain stents, the rate of reoccurrence of artery narrowing can be lowered. For instance, Acclino microstent offered by Acandis GmbH, shows a satisfactory safety profile and a promising rate of immediate and mid-term complete aneurysm occlusion for stent-assisted coil embolization in wide-neck intracranial aneurysms.

The global intracranial stents market size was valued at US$ 313.5 million in 2017, and is expected to witness a CAGR of 15.6% over the forecast period (2018 – 2026).

Figure 1. Global Intracranial Stents Market Share Analysis (%), By Region, 2017

Intracranial Stents | Coherent Market Insights

Source: Coherent Market Insights Analysis (2018)

Intracranial Stents Market Dynamics

Increasing incidence of stroke and brain aneurysm is propelling demand for intracranial stents. According to the Brain Aneurysm Foundation (BAF), brain aneurysm accounts for around 500,000 deaths worldwide annually. Moreover, BAF estimates that aneurysm is predominant in the age group of 35–60 years. Furthermore, high prevalence of stroke among geriatric population worldwide is also expected to propel demand for intracranial stents in the near future. According to the data published in the Medscape, 2010, around 75-89% of strokes occur in individuals aged > 65 years. Of these strokes, 50% occur in people who are aged ≥ 70 years and nearly 25% occur in individuals who are aged > 85 years.

Integration of advanced software with existing products are gaining significant traction among various market players of intracranial stents with affordable costs thus, expected to drive intracranial stents market growth. For instance, in September 2016, Medtronic plc received the U.S. Food and Drug Administration (FDA) approval for its StealthStation, which is integrated with Medtronic’s latest O-arm Imaging System, enabling clinicians to place the deep brain stimulation (DBS) leads with high level of accuracy during the cranial procedures.

However, high cost of the procedure and limited use of various intracranial stents to a small population may impact the overall market to some extent. For instance, in August 2012, the U.S. FDA approved label changes for the Wingspan Stent System offered by Stryker Corporation, reflecting changes in indications for use, and limiting the system to a much smaller group of patients between 22 and 80 years with intracranial stenosis.

Intracranial Stents Market Regional Outlook

On the basis of geography, the global intracranial stents market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to hold dominant position in this market, owing to increasing geriatric population who are more prone to brain diseases and adoption of technologically advanced products such as adoption of cranio maxillofacial implants. Emerging economies are also projected to witness significant growth in market over the forecast period, owing to high prevalence of intracranial strokes. For instance, according to the American Journal of Neuroradiology, 2011, intracranial cerebral atherosclerosis disease (ICAD) accounts for around 8%–10% of all ischemic strokes with a higher reported incidence in the Asian, African, and Hispanic descent populations. The factors responsible for disease prevalence in these regions includes cigarette smoking, hypertension, insulin-dependent diabetes mellitus, and hypercholesterolemia. Thus, emerging economies such as Asia Pacific and Latin America is likely to be the fastest growing region throughout the forecast period.

Major companies operating in the global intracranial stents market include Medtronic Plc, Balt Extrusion S.A., MicroPort Scientific Corporation, Abbott Laboratories, Stryker Corporation, Admedes Schuessler GmbH, Cardiatis, S.A, DePuy Synthes, Acandis GmbH, and Penumbra, Inc.

About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We do offer wide range of services such as Industry analysis, Consulting services, Market Intelligence, Customized research services and much more. We have expertise in many fields such as healthcare, chemicals and materials, Automation, semiconductors, electronics, energy, food and beverage, packaging and many more. Visit our website to know more.

Buy Report Here:

https://www.coherentmarketinsights.com/insight/buy-now/1870

Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave. #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]

#Market Analysis #Market Research #Coherent Market Insights

0 notes

supermarkettrends · 4 years ago

Text

Artery Stenosis Drug Market Will Accelerate Rapidly with Top Influencing Key players | Pfizer Inc, Eli Lilly and Company, Bristol-Myers Squibb Company.

Artery Stenosis Drug Market is a narrowing of the arteries that supply oxygen rich blood to vital organs and tissues such as brain, kidney and limbs. The causes of Artery stenosis is the deposition of plaque (atherosclerosis) inside the artery wall which reduces blood flow to the vital organs and tissues. Mostly people suffering from artery stenosis have no symptoms until the artery becomes severely narrowed. Symptoms generally occur with a mini-stroke followed by dizziness, fainting and blurred vision.

Artery stenosis drug market is expected to grow with the substantial CAGR in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. This rise in market value can be attributed to rising patient awareness regarding early detection, prevention, and treatment of strokes.

Get Sample Report at :

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-artery-stenosis-drug-market

Competitive Analysis: Global Artery Stenosis Drug Market

Few of the major competitors currently working in Global Artery Stenosis Drug Market are Abbott, GlaxoSmithKline plc, ALLERGAN, Novartis AG, Merck & Co., Inc, Sanofi, Pfizer Inc, Eli Lilly and Company, Bristol-Myers Squibb Company, CELGENE CORPORATION, Takeda Pharmaceutical Company Limited, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, Baxter, Medtronic, Johnson & Johnson Services, Inc, Cook Group among others.

Key Pointers Covered in the Global Artery Stenosis Drug Market Trends and Forecast to 2026

Global Artery Stenosis Drug Market New Sales Volumes

Global Artery Stenosis Drug Market Replacement Sales Volumes

Global Artery Stenosis Drug Market Installed Base

Global Artery Stenosis Drug Market By Brands

Global Artery Stenosis Drug Market Size

Global Artery Stenosis Drug Market Procedure Volumes

Global Artery Stenosis Drug Market Product Price Analysis

Global Artery Stenosis Drug Market Healthcare Outcomes

Global Artery Stenosis Drug Market Cost of Care Analysis

Global Artery Stenosis Drug Market Regulatory Framework and Changes

Global Artery Stenosis Drug Market Prices and Reimbursement Analysis

Global Artery Stenosis Drug Market Shares in Different Regions

Recent Developments for Global Artery Stenosis Drug Market Competitors

Global Artery Stenosis Drug Market Upcoming Applications

Global Artery Stenosis Drug Market Innovators Study

Get Detailed TOC:

https://www.databridgemarketresearch.com/toc/?dbmr=global-artery-stenosis-drug-market

Key Developments in the Market:

In February 2019, M.A. MedAlliance SA received Breakthrough Device designation from the U.S FDA for selution, sirolimus, sustained limus release (SLR) drug-eluting balloon (DEB) catheter, to treat coronary disease. This designation will provide company with the priority review and assistance from the FDA regarding device development and its approval.

In October 2018, Johnson & Johnson Services, Inc received the U.S FDA approval for Xarelto (rivaroxaban), factor Xa (FXa) inhibitor for the treatment of chronic coronary or peripheral artery disease. This drug is specifically approved for reducing the risk of major cardiovascular disorders such as stroke and myocardial infarction in patients with chronic coronary artery disease (CAD) or peripheral artery disease (PAD).

Scope of the Artery Stenosis Drug Market

Global Artery Stenosis Drug Market By Indication Type (Carotid Artery Stenosis, Renal Artery Stenosis, Peripheral Artery Stenosis, Coronary Artery Stenosis and Others), Treatment (Medication and Surgery), Drugs (Atorvastatin, Fluvastatin, Heparin, Minoxidil, Aspirin and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2027

Artery stenosis is a narrowing of the arteries that supply oxygen rich blood to vital organs and tissues such as brain, kidney and limbs. The causes of Artery stenosis is the deposition of plaque (atherosclerosis) inside the artery wall which reduces blood flow to the vital organs and tissues. Mostly people suffering from artery stenosis have no symptoms until the artery becomes severely narrowed. Symptoms generally occur with a mini-stroke followed by dizziness, fainting and blurred vision.

Speak to Author :

https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-artery-stenosis-drug-market

Key insights in the report:

Complete and distinct analysis of the market drivers and restraints

Key Market players involved in this industry

Detailed analysis of the Market Segmentation

Competitive analysis of the key players involved

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Browse Related Report Here:

North America Nasal Spray Market

Chronic Iron Overload Market

#Artery Stenosis Drug Market #Artery Stenosis Drug Market share #Artery Stenosis Drug Market size #Artery Stenosis Drug Market trends #Artery Stenosis Drug Market news #Artery Stenosis Drug Market report #Artery Stenosis Drug Market growth

0 notes

healthpackageservicesatultrascan · 23 days ago

Text

Comprehensive Guide to Doppler Ultrasound: Types, Benefits, and Cost Breakdown

Doppler ultrasound is an essential diagnostic tool used by healthcare professionals to assess blood flow and detect vascular abnormalities. From monitoring fetal health with a fetal Doppler scan to diagnosing renal artery stenosis through a renal Doppler test, this advanced imaging technique provides valuable insights into a variety of medical conditions. In this guide, we'll explore what Doppler ultrasound is, its uses, the different types of Doppler tests, and the cost of getting a Doppler scan near me. We will also answer common questions related to this diagnostic procedure.

What is Doppler Ultrasound?

Doppler ultrasound is a non-invasive imaging technique that uses high-frequency sound waves to measure and visualize blood flow in the arteries and veins. By sending sound waves into the body and recording their reflections off moving blood cells, this test provides valuable information about blood flow speed, direction, and any obstructions or abnormalities in the blood vessels.

The primary principle behind Doppler ultrasound is the Doppler effect, which refers to the change in frequency of sound waves as they bounce off moving objects, such as blood cells. These changes are then used to create real-time images or audio representations of the blood flow.

Types of Doppler Ultrasound Tests

Doppler ultrasound is used for a wide range of diagnostic purposes, depending on the area of the body being examined. Let’s explore the different types of Doppler tests that doctors commonly use:

1. Colour Doppler Ultrasound in Pregnancy

A colour Doppler ultrasound in pregnancy is an important test that helps monitor the blood flow between the mother and the fetus. It assesses the flow of blood in the placenta, umbilical cord, and fetal blood vessels. This test can identify complications like intrauterine growth restriction (IUGR), placental insufficiency, or signs of fetal distress.

The colour Doppler technique uses colour to display the direction and speed of blood flow. Red and blue colours indicate blood flowing toward and away from the probe, while the intensity of the colours represents the flow speed. This scan is a non-invasive and safe way to monitor the baby’s health throughout pregnancy.

2. Renal Doppler Test

A renal Doppler test is used to assess the blood flow in the kidneys. It helps doctors diagnose conditions such as renal artery stenosis, which is a narrowing of the renal arteries that can lead to high blood pressure and kidney damage. The test helps to visualize any blockages, narrowing, or abnormalities in the renal arteries, which is crucial for preventing kidney failure.

The renal Doppler test is typically recommended for patients with high blood pressure, kidney disease, or those who show signs of kidney dysfunction.

3. Carotid Doppler Test

A carotid Doppler test is used to evaluate the blood flow in the carotid arteries, which supply oxygen-rich blood to the brain. It is particularly important in detecting carotid artery disease, which involves plaque buildup that can block blood flow and increase the risk of stroke. Using Doppler ultrasound, doctors can visualize the degree of plaque buildup and any narrowing in the arteries.

This test is often performed in patients with high blood pressure, high cholesterol, or a family history of stroke.

4. Penile Doppler Test

A penile Doppler test is used to measure blood flow to the penis and is typically performed to diagnose erectile dysfunction (ED). The test helps determine if poor blood flow is causing the condition, which may be the result of blockages in the penile arteries. It is particularly useful for diagnosing vascular erectile dysfunction.

By assessing the blood flow in the penile arteries, doctors can identify potential causes of ED and recommend treatments such as medications, lifestyle changes, or surgical interventions.

5. Renal Artery Doppler

A renal artery Doppler test is specifically focused on the blood flow to the kidneys through the renal arteries. This test is crucial for diagnosing renal artery stenosis—a condition that can cause high blood pressure, kidney damage, or kidney failure. The Doppler ultrasound allows doctors to evaluate blood flow in these arteries and determine the severity of any blockages.

Early detection of renal artery stenosis can prevent complications such as kidney failure and high blood pressure.

6. Fetal Doppler Scan

A fetal Doppler scan is an important diagnostic tool used to monitor the well-being of the fetus during pregnancy. It listens to the fetal heartbeat and measures the blood flow in the placenta and umbilical cord. The test helps doctors detect signs of fetal distress, growth restrictions, and abnormalities in the fetal heart rate.

By using sound waves, the fetal Doppler scan is a safe, non-invasive procedure that provides important information about the baby’s health and development.

Benefits of Doppler Ultrasound

Doppler ultrasound offers many advantages over other diagnostic imaging methods. Some of the key benefits include:

Non-invasive: Doppler ultrasound does not require surgery, injections, or the use of radiation, making it a safe diagnostic tool for both children and adults.

Quick and efficient: The procedure typically takes 30-60 minutes, and results are available immediately.

Accurate diagnosis: Doppler ultrasound provides detailed and real-time images of blood flow, which helps doctors diagnose various conditions accurately.

Safe for pregnant women: Since Doppler ultrasound uses sound waves and not radiation, it is completely safe to perform during pregnancy, making it ideal for monitoring fetal health.

Versatile: Doppler ultrasound can assess blood flow in different parts of the body, including the brain, kidneys, and reproductive organs, making it an essential diagnostic tool for a variety of conditions.

What to Expect During a Doppler Ultrasound

Here is a step-by-step guide on what to expect during a Doppler ultrasound procedure:

Preparation: In most cases, you will be asked to wear comfortable clothing or a hospital gown. For some tests, you may be advised to avoid eating or drinking before the procedure.

Gel Application: A special gel will be applied to the skin where the ultrasound will be performed. This gel helps transmit the sound waves and ensures clear images.

Procedure: The technician will use a small handheld device called a transducer to send sound waves into the body. The transducer is moved over the skin to capture the images and sound waves that reflect off the blood cells.

Completion: After the test, the gel will be wiped off, and you can resume your normal activities. In most cases, the doctor will provide you with the results shortly after the test or schedule a follow-up appointment.

Doppler Ultrasound Cost

The price of a Doppler ultrasound can vary depending on several factors, including the type of test, location, and healthcare provider.

Factors that affect the cost include:

Type of Doppler test: More specialized tests like fetal Doppler scans or carotid Doppler tests tend to be more expensive than basic tests like renal Doppler tests.

Location: Prices may vary based on your location and whether the test is performed in a hospital, outpatient clinic, or private diagnostic center.

Insurance: If you have health insurance, it may cover part or all of the cost. It’s a good idea to check with your insurance provider for coverage details.

If you’re located in Indore, trusted diagnostic centers like Health Scan Diagnostics provide reliable and affordable Doppler ultrasound services.

Commonly Asked Questions About Doppler Ultrasound

1. What is a Doppler ultrasound used for?

Doppler ultrasound is primarily used to assess blood flow in the arteries and veins. It helps diagnose conditions like vascular disease, kidney disease, stroke risk, and erectile dysfunction.

2. Is Doppler ultrasound safe during pregnancy?

Yes, Doppler ultrasound is completely safe during pregnancy. Unlike X-rays, Doppler ultrasound uses sound waves, making it a non-invasive and safe option for both the mother and the baby.

Conclusion

Doppler ultrasound is a crucial diagnostic tool that provides detailed information about blood flow and circulatory health. Whether you’re undergoing a fetal Doppler scan, renal Doppler test, or a carotid Doppler test, this non-invasive procedure plays a vital role in diagnosing and monitoring various health conditions.

If you’re looking for a Doppler test near me, contact a reputable quality diagnostic centre in Indore like Health Scan Diagnostics for affordable and high-quality testing.

[email protected] 78695 24599 451-G Greater Brajeshwari,Near Kerala Bakery,Pipliyahana Road, Pipliyahana, indore, Madhya Pradesh 452016

#health & fitness #healthcare #diagnostic ultrasound #diagnosticprocess

0 notes

researchtrendingnews · 5 years ago

Text

Artery Stenosis Drug Market Strategic Insights and key Business Influencing Factors | Major Players – Pfizer Inc, Eli Lilly and Company, Bristol-Myers Squibb Company.

Get Sample Report at :

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-artery-stenosis-drug-market

Competitive Analysis: Global Artery Stenosis Drug Market

Key Pointers Covered in the Global Artery Stenosis Drug Market Trends and Forecast to 2026

Global Artery Stenosis Drug Market New Sales Volumes

Global Artery Stenosis Drug Market Replacement Sales Volumes

Global Artery Stenosis Drug Market Installed Base

Global Artery Stenosis Drug Market By Brands

Global Artery Stenosis Drug Market Size

Global Artery Stenosis Drug Market Procedure Volumes

Global Artery Stenosis Drug Market Product Price Analysis

Global Artery Stenosis Drug Market Healthcare Outcomes

Global Artery Stenosis Drug Market Cost of Care Analysis

Global Artery Stenosis Drug Market Regulatory Framework and Changes

Global Artery Stenosis Drug Market Prices and Reimbursement Analysis

Global Artery Stenosis Drug Market Shares in Different Regions

Recent Developments for Global Artery Stenosis Drug Market Competitors

Global Artery Stenosis Drug Market Upcoming Applications

Global Artery Stenosis Drug Market Innovators Study

Get Detailed TOC:

https://www.databridgemarketresearch.com/toc/?dbmr=global-artery-stenosis-drug-market

Key Developments in the Market:

Scope of the Artery Stenosis Drug Market

Speak to Author :

https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-artery-stenosis-drug-market

Key insights in the report:

Complete and distinct analysis of the market drivers and restraints

Key Market players involved in this industry

Detailed analysis of the Market Segmentation

Competitive analysis of the key players involved

About Us:

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Browse Related Report Here:

North America Nasal Spray Market

Chronic Iron Overload Market

0 notes

martynnx-blog · 6 years ago

Text

Intracranial Stents Market 2026 Growth Trends by Manufacturers, Regions, Type and Application, Forecast

The global intracranial stents market size was valued at US$ 313.5 million in 2017, and is expected to witness a CAGR of 15.6% over the forecast period (2018 – 2026).

Market Dynamics

Factors such as increasing prevalence of brain aneurysms and stroke, government programs to decrease the burden of traumatic brain injury, technological advancements plugging treatment gaps and availability of reimbursement are propelling demand for intracranial stents. However, high cost and stringent government regulations is negatively impacting growth of the market. Companies are therefore, adopting different strategies such as providing FDA approved on-site training, strategic collaborations, and technology upgrades in order to increase their market presence and engage with customers. For instance, in January 2018, Stryker announced the positive results of WEAVE, the post market surveillance study of the company’s Wingspan stent system, for the patients suffering from intracranial atherosclerotic disease (ICAD). Thus, providing more opportunities in procedural approach with significant results.

Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1870

Intracranial Stents Market Regional Outlook

Major Key Players:

#Intracranial Stents Market #Intracranial Stents Market 2018 #intracranial stents

0 notes

healthcaremarket242-blog · 6 years ago

Text

Global Interventional Neurology Market To Mirror A Worldwide Expansion Throughout 2018 – 2026

Tissue plasminogen activators (tPAs) are used for treatment of stroke, aneurysms, stenosis, and vascular malformations. A study published in the New England Journal of Medicine stated that Neurointerventional surgery in addition to IV-administered "clot-busting" tissue plasminogen activator (IV-tPA) therapy is more effective than administering IV-tPA alone for the treatment of stroke.

According to the Brain Aneurysm Foundation (BAF), brain aneurysm accounts for around 500,000 deaths each year. BAF estimates that aneurysm is predominant in the age group of 35–60 years. Moreover, globally around 15 million people suffer a stroke every year, as per stats released by the World Heart Federation. High incidence of stroke and brain aneurysm is contributing to increasing demand for interventional neurology devices. Furthermore, introduction of new techniques such as flow diverter and aspiration are propelling demand for interventional neurology devices. The global Interventional neurology market was valued at US$ 1,694.5 million in 2015 and is expected to expand at a CAGR of 5.3% during the forecast period (2016 – 2024).

Market dynamics

Factors such as increasing prevalence of brain aneurysms, and stroke, government programs to decrease the burden of traumatic brain injury, technological advancements plugging treatment gaps and availability of reimbursement are driving demand for neurointerventional devices. However, high cost and negative perception about neurointerventional devices is impacting the demand negatively. Companies are therefore, adopting different strategies such as providing FDA approved on-site training, strategic collaborations, and technology upgrades in order to increase their market presence and engage with customers.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/56

Market Taxonomy

This report segments the interventional neurology market on the basis of product type, technique, therapeutic application and end use. On the basis of product type the market has been segmented into embolic coils, carotid stents, intracranial stents, neurovascular thrombectomy devices, embolic protection devices, and flow diverter devices. On the basis of technique, the market is segmented into Neurothrombectomy Procedure, Cerebal Angiography Technique, Stenting Technique, Coiling Procedure Technique, and Flow Disruption Technique. The therapeutic application of interventional neurology devices include brain aneurysm, ischemic strokes, artery stenosis, vein stenosis and others. In terms of end use, the global interventional neurology market is analyzed for hospitals and ambulatory centers. The market is also analyzed across major geographies namely North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

Key features of the study:

This report provides in-depth analysis of neurointerventional devices and their usage preferences

This study provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2016 – 2024), considering 2015 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this industry

This study provides vital insights about market drivers, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the market players

The report takes into account these factors in addition to the critical limiting factors and evolving industry trends while analyzing the market value and growth (%) during the forecast period

Detailed Segmentation:

Global Interventional Neurology Market, By Product Type:

Embolic coils, Carotid stents, Intracranial stents, Neurovascular thrombectomy devices, Embolic protection devices, Flow diverter devices, Intravascular Devices, Liquid Embolic Devices, Balloons, Stent Retrievers

Market players need to address demand-shift in devices and procedural techniques

The global Interventional neurology market is undergoing a demand-shift in terms of products and techniques to treat stroke and aneurysms. For instance, demand for bare platinum coils is growing at a rapid pace as compared to that for coated coils. This is mainly due to high costs of coated coils and their less improved clinical outcomes compared to bare platinum coils. The highly touted International Subarachnoid Aneurysm Trial (ISAT) demonstrated improved clinical outcomes with coils rather than clipping, which resulted in decline in the usage of clips in neurovascular surgery.

Strategic channel distribution agreements among manufacturers to bolster their regional reach

Codman Neuro entered into agreement with InNeuroCo, Inc. for the European distribution rights for intermediate catheters (ICs). Similarly, Covidien (now Medtronic) entered into an exclusive distribution agreement with Pulsar Vascular, Inc. to market and promote PulseRider in Europe, the Middle East, and Africa. PulseRider is a minimally invasive device intended for use (with embolic coils) for treatment of unruptured wide-neck intracranial aneurysms. Such strategic distribution partnership are helping market leaders to expand their global footprint. Click To Read More On Interventional Neurology Market

#Interventional Neurology Market #Interventional Neurology Market Share #Interventional Neurology Market Outlook #Interventional Neurology Market Analysis

0 notes

perfectdonutobservation · 4 years ago

Text

Global Neurovascular Devices Market

Global Neurovascular Devices Market was valued US$ XX Bn in 2018 and is expected to reach US$ 4.34 Bn by 2026, at CAGR of XX% during forecast period. The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.

Increasing patient demand for slightly invasive surgeries will augment neurovascular devices business growth during the forecast period. Advancement of innovative technology has led to significant demand for procedures with minimum invasion. Slightly invasive procedures offering benefits to the patients including decreased pain, less blood loss and cost-effectiveness will increase adoption of neurovascular surgeries, these factors will also help to accelerate neurovascular devices market growth.

Furthermore, Technological advancements in neurovascular devices will help as a high impact rendering factor for neurovascular devices industry growth. Additionally, a growing number of cases of a brain aneurysm and ischemic stroke across the U.S. will be a major factor driving market growth. Ischemic stroke is the highest occurring subtype of stroke in the U.S. and stroke is the fourth leading mortality factor. According to The American Journal of Medicine, approximately 795,000 strokes occur each year in the country. With increasing geriatric population across the country, the burden of ischemic stroke is rapidly rising that will result in substantial demand for neurovascular devices over the upcoming years

At the same time, the greater cost associated with neurovascular devices and treatment can reduce the adoption and customer preference for the devices. Furthermore, challenges pertaining to commercialization of neurovascular devices due to lack of resources and proper business environment across emerging economies may restrict neurovascular devices market growth in the foreseeable future.

Based on type, Embolic coils product segment accounted for the largest market size of USD XX million in 2017. Minimal invasion, shape and size flexibility these benefits offered by embolic coils will contribute to the segmental growth. Embolic coils are cost-effective and offer sub-optimal angiographic results. With increasing patient suffering from a brain aneurysm, neurovascular devices market will foresee a remarkable increase in demand during the forecast period.

Among the regions, Asia-Pacific holds the largest share of neurovascular devices market, in 2017. This region is expected to continue its dominance during the forecast period. North America accounted for the largest market share of the total market in 2017 and is expected to hold the top position over the forecast period. Key factors driving this growth include favorable reimbursement structure, especially in the U.S., extensive R&D investments, and wide product usage by neurosurgeons supported by the availability of advanced technologies with higher efficiency and reliability. The Asia Pacific is the fastest-growing region, with India and China on the forefront. Major revenue contributor in this region is Japan, which is anticipated to maintain dominance during the forecast period, on account of increasing awareness about neurovascular diseases and its management.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding the global neurovascular devices market dynamics, structure by identifying and analysing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the global neurovascular devices market. Scope of Global Neurovascular Devices Market:

Global Neurovascular Devices Market, By Type:

• Cerebral Embolization and Aneurysm Coiling Devices o Embolic Coils o Flow Diversion Devices o Liquid Embolic Agents • Cerebral Angioplasty and Stenting Systems o Carotid Artery Stents o Embolic Protection Systems • Neurothrombectomy Devices o Clot retrieval Devices o Suction Devices o Vascular Snares • Support Devices o Micro Catheters o Micro Guidewires Global Neurovascular Devices Market, By Therapeutic Application:

• Stroke • Cerebral Artery Stenosis • Cerebral Aneurysm • Others Global Neurovascular Devices Market, By End-user:

• Hospitals • Clinics • Ambulatory Surgical Centers Others Global Neurovascular Devices Market, By Region:

• North America • Europe • Asia-Pacific • South America • Middle East & Africa Key Players Operated in Market Include:

• Stryker Corporation • Medtronic plc • Johnson & Johnson • Terumo Corporation • Penumbra, Inc. • Abbott Laboratories • Merit Medical Systems, Inc. • W. L. Gore & Associates, Inc. • MicroPort Scientific Corporation For More Information Visit @: https://www.maximizemarketresearch.com/

This Report Is Submitted By :Maximize Market Research Company Customization of the report: Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contact info: Name: LumawantGodage Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD. Email: [email protected] Address:Pune, Maharashtra 411051, India. Contact: +919607195908

#Neurovascular Devices Market

0 notes